Avian Disease and Oncology Laboratory Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
 

Title: RETICULOENDOTHELIOSIS IN CHICKENS

Author

Submitted to: Poultry Health Conference Proceedings
Publication Type: Proceedings
Publication Acceptance Date: March 30, 1995
Publication Date: N/A

Technical Abstract: Reticuloendotheliosis (RE) is a neoplastic disease condition of poultry caused by an avian retrovirus (REV). The virus can be transmitted horizontally from chick-to-chick or vertically from dams to progeny. Previous serological surveys and current field observations suggest that infection with REV is widespread, but the disease has not emerged as an important disease problem for commercial chicken flocks. Experimental infection of chickens with REV causes nerve lesions similar to those of Marek's disease (MD) and B- or T-cell lymphomas that resemble lymphoid leukosis (LL) and MD, respectively. REV also causes a runting disease characterized by severe atrophy of the lymphoid organs, poor growth and abnormal feathering. Accidental contamination of commercial vaccines with REV is considered as a source of virus infection and can cause runting disease as well as lymphomas in vaccinated chickens. REV infection can be diagnosed by a number of biological and molecular assays. Currently, efforts to control REV infection in commercial breeder flocks are minimal. A program similar to that used in reduction or eradication of avian leukosis virus in primary egg-laying breeders may be necessary to control REV infection in chickens. Recently developed recombinant vaccines containing the env gene of REV can be used in conjunction with any program aimed at control of REV infection.

   
 
 
Last Modified: 06/17/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House